These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 8139570)

  • 1. Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase.
    Kato JY; Matsuoka M; Strom DK; Sherr CJ
    Mol Cell Biol; 1994 Apr; 14(4):2713-21. PubMed ID: 8139570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of cyclin-dependent kinase 4 (cdk4) by mouse MO15-associated kinase.
    Matsuoka M; Kato JY; Fisher RP; Morgan DO; Sherr CJ
    Mol Cell Biol; 1994 Nov; 14(11):7265-75. PubMed ID: 7935441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dominant-negative cyclin D1 mutant prevents nuclear import of cyclin-dependent kinase 4 (CDK4) and its phosphorylation by CDK-activating kinase.
    Diehl JA; Sherr CJ
    Mol Cell Biol; 1997 Dec; 17(12):7362-74. PubMed ID: 9372967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-type cyclin-dependent kinase activity in mammalian cells.
    Matsushime H; Quelle DE; Shurtleff SA; Shibuya M; Sherr CJ; Kato JY
    Mol Cell Biol; 1994 Mar; 14(3):2066-76. PubMed ID: 8114738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6.
    Hirai H; Roussel MF; Kato JY; Ashmun RA; Sherr CJ
    Mol Cell Biol; 1995 May; 15(5):2672-81. PubMed ID: 7739547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity.
    Lukas J; Bartkova J; Rohde M; Strauss M; Bartek J
    Mol Cell Biol; 1995 May; 15(5):2600-11. PubMed ID: 7739541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.
    Prall OW; Sarcevic B; Musgrove EA; Watts CK; Sutherland RL
    J Biol Chem; 1997 Apr; 272(16):10882-94. PubMed ID: 9099745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway.
    Diehl JA; Zindy F; Sherr CJ
    Genes Dev; 1997 Apr; 11(8):957-72. PubMed ID: 9136925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The proto-oncogene c-myc acts through the cyclin-dependent kinase (Cdk) inhibitor p27(Kip1) to facilitate the activation of Cdk4/6 and early G(1) phase progression.
    Obaya AJ; Kotenko I; Cole MD; Sedivy JM
    J Biol Chem; 2002 Aug; 277(34):31263-9. PubMed ID: 12070150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contact inhibition-induced inactivation of the cyclin D-dependent kinase in rat fibroblast cell line, 3Y1.
    Kato A; Takahashi H; Takahashi Y; Matsushime H
    Leukemia; 1997 Apr; 11 Suppl 3():361-2. PubMed ID: 9209390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential phosphorylation of T-47D human breast cancer cell substrates by D1-, D3-, E-, and A-type cyclin-CDK complexes.
    Sarcevic B; Lilischkis R; Sutherland RL
    J Biol Chem; 1997 Dec; 272(52):33327-37. PubMed ID: 9407125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic AMP-dependent phosphorylation of cyclin D3-bound CDK4 determines the passage through the cell cycle restriction point in thyroid epithelial cells.
    Paternot S; Coulonval K; Dumont JE; Roger PP
    J Biol Chem; 2003 Jul; 278(29):26533-40. PubMed ID: 12730225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDK4/cyclin D1/PCNA complexes during staurosporine-induced G1 arrest and G0 arrest of human fibroblasts.
    Gadbois DM; Peterson S; Bradbury EM; Lehnert BE
    Exp Cell Res; 1995 Sep; 220(1):220-5. PubMed ID: 7664838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors.
    Parry D; Mahony D; Wills K; Lees E
    Mol Cell Biol; 1999 Mar; 19(3):1775-83. PubMed ID: 10022865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G1 phase arrest induced by Wilms tumor protein WT1 is abrogated by cyclin/CDK complexes.
    Kudoh T; Ishidate T; Moriyama M; Toyoshima K; Akiyama T
    Proc Natl Acad Sci U S A; 1995 May; 92(10):4517-21. PubMed ID: 7753836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of G1 progression by D-type cyclins: key event for cell proliferation.
    Kato JY
    Leukemia; 1997 Apr; 11 Suppl 3():347-51. PubMed ID: 9209386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.
    Hsieh FF; Barnett LA; Green WF; Freedman K; Matushansky I; Skoultchi AI; Kelley LL
    Blood; 2000 Oct; 96(8):2746-54. PubMed ID: 11023508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells.
    Carlson BA; Dubay MM; Sausville EA; Brizuela L; Worland PJ
    Cancer Res; 1996 Jul; 56(13):2973-8. PubMed ID: 8674031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).
    Depoortere F; Pirson I; Bartek J; Dumont JE; Roger PP
    Mol Biol Cell; 2000 Mar; 11(3):1061-76. PubMed ID: 10712520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4.
    Blain SW; Montalvo E; Massagué J
    J Biol Chem; 1997 Oct; 272(41):25863-72. PubMed ID: 9325318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.